Homozygous targeted mutants exhibit skeletal and cardiac myopathies. Neuromuscular junctions appear to form normally, but their postnatal maturation is compromised. Dtna mutations do not increase the severity of Dmd or Utrn mutants whose products are also part of the dystrophin-glycoprotein complex.
|Ensembl Gene Model||ENSMUSG00000024302 (Evidence)|
|Entrez Gene||13527 (Evidence)|
|DFCI||TC1594198, TC1589021, TC1580290, TC1588833, TC1587820, TC1583715, TC1622870, TC1599521, TC1644790, TC1699827|
|DoTS||DT.50316348, DT.110776010, DT.101375171, DT.101375170, DT.101375169, DT.101360547, DT.91369218, DT.55117944, DT.55122692, DT.91359423, DT.60101497, DT.55282735, DT.91393353|
|NIA Mouse Gene Index||U056950, U018474|
|Consensus CDS Project||CCDS29094.1, CCDS50236.1|
|International Mouse Phenotyping Consortium Status||Dtna|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update